Bruker, Kiestra Ink Co-marketing Pact for Microbiology Mass Spec System

Apr 09, 2010

NEW YORK (GenomeWeb News) – Bruker Daltonics and Kiestra Lab Automation said today that they have expanded a co-marketing and cross-selling partnership covering the use of their technologies in microbiology laboratories.

The companies have also signed a research and development agreement to integrate Bruker's MALDI Biotyper and Kiestra’s MalditofA, an automatic colony picker.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

French Funding Agency Head Resigns

The president of France's National Research Agency has resigned, according to Nature News.

Right to Try Versus Clinical Trials

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.